Table 3 Meta analysis results for the association of over-expressed SNHG20 with clinicopathological parameters
From: Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysis
Categories | Studies (n) | Number of patients | OR (95% CI) | P value | Heterogeneity | Begg | Egger | ||
|---|---|---|---|---|---|---|---|---|---|
I2 (%) | P value | Model | |||||||
Gender (male vs female) | 13 | 1034 | 0.96 (0.74, 1.25) | 0.763 | 0.00 | 0.607 | Fixed-effect | 0.951 | 0.792 |
Smoking status (yes vs no) | 3 | 137 | 1.16 (0.59, 2.28) | 0.676 | 0.00 | 0.439 | Fixed-effect | – | – |
Distant metastasis (yes vs no) | 5 | 502 | 1.28 (0.35, 4.71) | 0.706 | 84.50 | 0.000 | Random-effect | – | – |
TNM stage (III/IV vs I/II) | 9 | 591 | 2.80 (2.00, 3.93) | 0.000 | 13.90 | 0.318 | Fixed-effect | 0.348 | 0.389 |
Tumor size (> 5 cm vs < 5 cm) | 6 | 478 | 3.08 (2.11, 4.51) | 0.000 | 0.00 | 0.753 | Fixed-effect | – | – |
Lymph node metastasis (yes vs no) | 8 | 534 | 2.99 (2.08, 4.31) | 0.000 | 45.00 | 0.079 | Fixed-effect | – | – |
Tumor stage (T3/T4 vs T1/T2) | 3 | 203 | 4.51 (2.17, 9.37) | 0.000 | 0.00 | 0.943 | Fixed-effect | – | – |
Histological grade (poorly vs well/moderately) | 9 | 844 | 1.95 (1.44, 2.63) | 0.000 | 6.00 | 0.385 | Fixed-effect | 0.602 | 0.575 |